Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bluebird Bio (BLUE)

Bluebird Bio (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 114,803
  • Shares Outstanding, K 109,336
  • Annual Sales, $ 3,600 K
  • Annual Income, $ -266,580 K
  • 60-Month Beta 0.81
  • Price/Sales 4.91
  • Price/Cash Flow N/A
  • Price/Book 0.55
Trade BLUE with:

Options Overview Details

View History
  • Implied Volatility 130.06% ( -11.84%)
  • Historical Volatility 88.57%
  • IV Percentile 49%
  • IV Rank 46.47%
  • IV High 232.70% on 12/07/23
  • IV Low 40.97% on 05/31/24
  • Put/Call Vol Ratio 0.39
  • Today's Volume 940
  • Volume Avg (30-Day) 901
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 70,039
  • Open Int (30-Day) 68,384

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.48
  • Number of Estimates 5
  • High Estimate -0.31
  • Low Estimate -0.69
  • Prior Year -0.67
  • Growth Rate Est. (year over year) +28.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8450 +24.26%
on 06/20/24
1.4300 -26.57%
on 07/16/24
+0.1394 (+15.31%)
since 06/18/24
3-Month
0.8450 +24.26%
on 06/20/24
1.4300 -26.57%
on 07/16/24
+0.0300 (+2.94%)
since 04/19/24
52-Week
0.8450 +24.26%
on 06/20/24
5.5300 -81.01%
on 12/08/23
-2.6200 (-71.39%)
since 07/19/23

Most Recent Stories

More News
Is Bluebird Bio Stock a Buy?

It won't be easy for the company to bounce back.

BLUE : 1.0500 (-8.70%)
Is Bluebird Bio Stock a Buy?

This small biotech is struggling to fly -- and investors should probably steer clear.

BLUE : 1.0500 (-8.70%)
Better Buy: Bluebird Bio Vs. Novavax

Who wins this face-to-face between two beaten-down biotechs?

BLUE : 1.0500 (-8.70%)
NVAX : 13.85 (-7.42%)
Is This Beaten-Down Stock a Good Acquisition Target?

This company has proven its innovative abilities, but that's not enough to outperform the market.

BLUE : 1.0500 (-8.70%)
Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst

Biotech stocks are famously volatile. One analyst feels this one could be volatile enough to produce an outsized gain.

WFC : 59.23 (-0.02%)
BLUE : 1.0500 (-8.70%)
Why Bluebird Bio Stock Flew Higher Than the Market Today

The company was thrown a financial lifeline.

HTGC : 21.18 (-0.05%)
BLUE : 1.0500 (-8.70%)
Is Bluebird Bio Stock a Buy Now?

Are you feeling brave?

BLUE : 1.0500 (-8.70%)
Why Bluebird Bio Stock Dived Into the Red on Tuesday

The biotech has had a tough time of it over the past few years; a pundit's revised take on the company won't improve that situation.

HSBC : 42.86 (-0.37%)
BLUE : 1.0500 (-8.70%)
If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today

The answer hardly inspires confidence.

BLUE : 1.0500 (-8.70%)
2 Red Flags for Bluebird Bio Stock

The biotech's struggles may continue.

VRTX : 491.57 (+0.71%)
CRSP : 54.56 (-2.94%)
BLUE : 1.0500 (-8.70%)

Business Summary

bluebird bio, Inc. is a clinical-stage biotechnology that is focused on developing gene therapies for severe genetic diseases and cancer. The company has developed a deep pipeline using lentiviral-based gene therapies, T-cell immunotherapy expertise, and gene editing capabilities to treat severe genetic...

See More

Key Turning Points

3rd Resistance Point 1.2571
2nd Resistance Point 1.2085
1st Resistance Point 1.1293
Last Price 1.0500
1st Support Level 1.0015
2nd Support Level 0.9529
3rd Support Level 0.8737

See More

52-Week High 5.5300
Fibonacci 61.8% 3.7403
Fibonacci 50% 3.1875
Fibonacci 38.2% 2.6347
Last Price 1.0500
52-Week Low 0.8450

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar